|
Pharm/Biotech
Patents Available for Licensing (US Government) |
The following patents are owned by the United
States Government and
available for licensing.
January 23, 2012
|
•
Notice (A):
Government-Owned Inventions; Availability for Licensing |
- Enhancement of Cancer
Imaging and Treatment With Somatostatin Analogs
- PARP Inhibitor/NO Donor Dual
Prodrugs as Anticancer Agents
- Small Molecule Drugs for
Treatment of Ataxia Telangiectasia or DNA Damage
- Transgenic Human
Interleukin-21 Mouse Model
- Method for Producing
Significant Amounts of B19 Virus for Development of Killed
or Attenuated Vaccines
- HIV Therapeutics Utilizing
Peptide Secreting Commensal Bacteria
|
|
•
Notice (B):
Government-Owned Inventions; Availability for Licensing |
- Thioxothiazolidinone
Derivatives--A Novel Class of Anti Cancer Agents
- Monospecific and Bispecific
Human Monoclonal Antibodies Targeting IGF-II
- Genetic Interactions That
Predict Attention Deficit Hyperactivity Disorder Outcome and
Severity
- Modulating Autophagy as a
Treatment for Lysosomal Storage Diseases
|
December 8, 2011
|
•
Notice:
Government-Owned Inventions; Availability for Licensing |
- Novel NSAIDs for the
Treatment of Human Diseases
- Fibroblast Growth Factor
Receptor 1 (Fgfr1) Conditional Knock Out Mouse
- Biomarkers for
Cancer-Related Fatigue and Their Use in the Management of
Such Fatigue (CRF)
- Characterizing Compartment
Distributions From Diffusion Weighted Magnetic Resonance (MR)
Data
- One Step Fluorine-18 Peptide
Labeling Strategy of Biological Substrates
|
November 25, 2011
|
•
Notice:
Government-Owned Inventions; Availability for Licensing |
- Genetically Engineered Mouse
Model for Use as an Alternative Screening Method for
Evaluating P-glycoprotein (P-gp) Substrate Toxicity in
- Avermectin-sensitive Dogs
- Treatment of
Tuberculosis--Adjuvant Therapies To Increase the Efficiency
of Antibiotic Treatments
- DPEP1 and TPX2 as Prognostic
Biomarkers for Pancreatic Ductal Adenocarcinoma
- AAV Mediated CTLA-4 Gene
Transfer To Treat Sj[ouml]gren's Syndrome
|
November 22, 2011
October 27, 2011
October 12, 2011
|
•
Notice:
Government-Owned Inventions; Availability for Licensing |
- Human Phospho-Serine134
Glucocorticoid Receptor Polyclonal Antibody: Useful for the
Characterization of Glucocorticoid Signaling Processes,
e.g., in Cancer and Inflammation
- Infectious Hepatitis E Virus
Genotype 3 Recombinants--Prospective Vaccine Candidates and
Vector System
- Diagnostic H5N1 Avian
Influenza Virus Peptides
|
October 5, 2011
|
•
Notice (A):
Government-Owned Inventions; Availability for Licensing |
- Platform Technology Using
Ubiquitin To Improve the Delivery and Efficacy of Cytosolic
Targeted Toxins
- NOX5 Immunogenic Peptides
and Monoclonal Antibodies for the Detection of Cancer and
Inflammatory Responses
- mGluR5 Tumor Mouse Model
- Monoclonal Antibodies to
FCRL5 (CD307e/IRTA2/FcRH5) as Therapeutics and Diagnostics
for B-cell Cancers
- Potent Inhibitory RNAs for
Non-Surgical Treatment of Salivary Gland Cancers
|
|
•
Notice (B):
Government-Owned Inventions; Availability for Licensing |
- Humanized Monoclonal
Antibodies Efficient for Neutralization of Tick-Borne
Encephalitis Virus (TBEV)
- Rapid Molecular Assays for
Specific Detection and Quantitation of Loa Loa
Microfilaremia
- Diagnostic Assays and
Methods of Use for Detection of Filarial Infection
- A System and Method for
Detecting Untoward Events in Hospitals
|
September 26, 2011
|
•
Notice:
Government-Owned Inventions; Availability for Licensing |
- A Novel Method To Predict
Kidney Tumor Growth
- Pharmaceutical Compounds for
the Treatment of Spinal Muscular Atrophy and Other Uses
- STAMP, A Novel Cofactor and
Possible Steroid Sparing Agent, Modulates Steroid-induced
Induction or Repression of Steroid Receptors
- A Biomarker and Therapeutic
Target for Ovarian Cancer
|
September 6, 2011
|
•
Notice (B):
Government-Owned Inventions; Availability for Licensing |
- Vaccine To Prevent BK
Polyomavirus-associated Kidney and Bladder Infections in
Organ Transplant Recipients
- Gas Permeable Flasks To Grow
Tumor Infiltrating Lymphocytes (TIL) for More Effective
Anti-Cancer Immunotherapy
- A Novel Optomechanical
Module that Enables a Conventional inverted Microscope To
Provide Selective Plane Illumination Microscopy (iSPIM)
- A Vaccine for Shigella
sonnei for Both Children and Adults
|
August 18, 2011
|
•
Notice:
Government-Owned Inventions; Availability for Licensing |
- Quantitative Measurement of
Syndesmophytes in Ankylosing Spondylitis Using Computed
Tomography (CT)
- An Automated Method for
Precise Measurement of Vertebral Body Height and
Intervertebral Disk Height Using Computed Tomography
- Monoclonal Antibodies
Against Poliovirus
- Methods of Treating
Giardiasis Using FDA-Approved Compounds
|
August 11, 2011
|
•
Notice:
Government-Owned Inventions; Availability for Licensing |
- Tumor Markers for
Potentially Predicting Outcome of Anti-angiogenesis Therapy
- TRRAP and GRIN2A Mutations
for the Diagnosis and Treatment of Melanoma
- Cells and Nanoparticles With
Altered Protein Expression Patterns Useful for the
Modulation of T Cell Activity for Immunotherapy
|
|
| |
| |
|
University of Colorado Executive MBA
Program in Health Administration offers an option in Pharmaceutical
Management, More...
|
|
George Washington University Healthcare MBA
provides healthcare professionals with a MBA degree from a top AACSB-accredited business
school in the US, More.... |
|
Pharm/Healthcare Business Intelligence Reports
specially selected for
PharmCast.com visitors.
More.... |
|
Training Courses
-- pharmaceutical, biotech, cosmetic, etc.
|
|
Jobs
-- pharmaceutical, biotech, R&D, clinical, regulatory, QA/QC,
sales, marketing, etc. |
|
Pharmaceutical
Software
-- pharmaceutical operation software, NOVA-LIMS, More... |
|
Covidien Pharmaceuticals Outsourcing
is a contract manufacturer specializing in high-quality solid dose and oral
liquid finished products, More.... |
|
Web Seminars --
pharmaceutical, biotech, clinical, etc. |
|
|
